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ABSTRACT (Maximum 200 Words)
Growing evidence from experimental and clinical studies confirms that solid human tumors have foci of hypoxic cells, which have a profound influence on the therapeutic outcome of cancer chemotherapy and radiotherapy. A strong argument therefore exists for assessing the hypoxic fraction of tumors prior to patient treatment, and to tailor this treatment accordingly. It has been shown that there is linear relationship between R1 of hexamethyldisiloxane (HMDSO) and pO2, and the R1 of HMDSO is insensitive to various ions and minimally sensitive to temperature. The primary sequence for in vivo T1 measurement with water and fat suppression has been established, which can successfully monitor the global tumor oxygenation responding to respiratory intervention by measuring HMDSO spinlattice relaxation time using spectroscopy. Although the imaging technique still needs to be optimized in tumor, pO2 maps accompanying respiratory intervention has been obtained in rat muscle. So, Hexamethyldisiloxane shows promise as a reporter molecule to measure tumor oxygenation by 1H MRS and potentially by MRI. This opens new opportunities for MR tumor oximetry, particularly since HMDSO is used widely in biomedical materials and as an ingredient in consumer products; and HMDSO is reported to have minimal toxicity.
Introduction:
Growing evidence from experimental and clinical studies confirms that solid human tumors have foci of hypoxic cells, which have a profound influence on the therapeutic outcome of cancer chemotherapy and radiotherapy: the level and severity of hypoxia can be a strong prognostic factor of disease progression and survival. A strong argument therefore exists for assessing the hypoxic fraction of tumors prior to patient treatment, and to tailor this treatment accordingly.
Baseline pO 2 and dynamic changes with respiratory intervention has been measured extensively in rat prostate tumors by 19 F MRI (FREDOM, Fluorocarbon Relaxometry using Echo planar imaging for Dynamic Oxygen Mapping) based on the spin-lattice relaxation of Hexafluorobenzene (HFB), which provides spatially resolved maps of tumor oxygenation at depth and allows monitoring of dynamic changes at specific locations. However, for clinical application 19 F NMR is not yet widely available. A proton MR analog of HFB could facilitate immediate widespread oximetry. We have identified hexamethyldisiloxane (HMDSO) as a potential reporter. HMDSO has extensive symmetry and a single proton resonance well removed from water.
We had three specific aims for this project:
Task1.
Characterize the effects of external factors on T1(spin-lattice relaxation time) of HMDSO in vitro and get the calibration curves, Month 1-6
Task2.
Develop relevant MR pulse sequences with H 2 O suppression for imaging. Establish experimental prostate tumor models and measure the retention time of HMDSO in tumors, Month 6-12
Task3.
Make pO 2 maps and measure prostate tumor oxygen dynamics with respect to growth rate and respiratory challenge, Month 12-24
Body:
Hexamethyldisiloxane (HMDSO) is used widely in biomedical materials and as an ingredient in consumer products, such as a thin polymeric coating on suture for cardiovascular surgery, or the thin layer onto the inner surface of plasma-modified small diameter tubing, etc. HMDSO is reported to have minimal toxicity. A previous test, in vitro indicated that the spin-lattice relaxation time of HMDSO was sensitive to oxygen tension. HMDSO is highly hydrophobic, and therefore can be injected intratumorally at specific sites and will not diffuse in the tumor. , the mixture of HMDSO+H2O, and the ion concentration is calculated according to the proportion of various ion in vivo. The T1 of these solutions were measured on 200MHz with various temperature and oxygen tension. It was found that there is no significant influence of various ions on spin-lattice relaxation rate, especially in the condition of lower oxygen tension that tumors have. R1 of HMDSO is only minimally sensitive to temperature. The correlation equation at 37 o C is R1=0.13+0.00175x (X is oxygen tension (torr)). For pedicle tumor: A flap of depilated skin is raised from the body of young adult male Copenhagen rat and held in position with a non-traumatic curved bull-dog clip. A 3cm incision is made through the skin using the curved edge of the clip as guide. Would clips are used to join the edge of the skin producing a tube resembling a suitcase handle. Two weeks later, the clips are removed and the distal end of the pedicle severed. A piece of fresh tumor tissue (2x2x2mm 3 ) is implanted in the lumen and the cut closed with a wound clip.
b. I used selected sublines of the Dunning prostate tumor in rats to measure the retention time of HMDSO in tumor. 100 μl HMDSO was injected intratumorally into Dunning prostate 3327 AT1 and H tumor, and PRESS pulse sequence with water suppression was used to acquire data. It was shown that HMDSO can remain at least 24hr within prostate tumor. c. With the assistance of Dr. Vikram Kodibagkar, the MR scientist, a special pulse sequence to suppress the resonance of H2O and fat while meaning relaxation is designed and implemented.
For T1 measurements by spectroscopy, a pulse burst saturation recovery (PBSR) sequence consisting of 20 nonselective 90 o pulses for saturation of signal followed by a delay tau for magnetization recovery and a single, frequency selective 90 o pulse for signal detection was used. T1 values were measured using this sequence with the ARDVARC (Alternating Relaxation Delays with Variable Acquisitions for Reduction of Clearance effects) protocol. For imaging experiments a spin-echo EPI based PBSR pulse sequence is being designed for measuring T1 values. The sequence consists of a) a train of 20 non-selective 90 o pulses for saturation of signal followed by a delay tau for magnetization recovery, b) three optional CHESS pulses for frequency selective saturation of residual water and fat immediately followed by c) spin-echo EPI detection with a slice selective 90 o pulse and a frequency selective 180 o pulse.
Task 3a.
Measure baseline pO 2 of tumors and make the pO 2 map (Dr. Vikram Kodibagkar, a MR scientist in the Department of Radiology at UTSW collaborated and assisted me in the task)
We reported that the pulse sequence (Fig1) with fat and water suppression developed by Dr. Kodibagkar worked very well with phantom. When it was used in Copenhagen rat thigh, the water and fat suppression are very effective, and baseline pO 2 map was obtained (Fig 2) . However, when this pulse sequence was used in tumor, water and fat suppression was incomplete; therefore, HMDSO imaging was less satisfactory. This maybe can be ascribed to different physiological characteristics of tumor and muscle, and tumor has more fat. 
I.
As a proof or principle, the global oxygen dynamics curve (Fig 3) and pO 2 maps (Fig4) responding to respiratory challenge is successfully measured using pulse sequence in rat thigh muscle. During the experiment, the rat was breathing air-oxygen-air. Fig6. The average pO 2 value during respiratory intervention III. Oximetry based on HMDSO imaging in tumor is still under development. It is more difficult to implement than in muscle. While continuing to tackle this problems, I have explored application of BOLD (Blood Oxygen Level Dependent) imaging in Dunning prostate rat tumor. During the experiment, the rat was breathing 15min air-25min oxygen-20min air. The data were normalized using the initial intensity. Fig 7 shows the signal intensity changed with gas challenge for individual data point. Table 2 
Conclusions:
The above experiments showed that: 1) As a imaging technique, it has been proved that the chemical shift select imaging of HMDSO with water and fat suppression can successfully measure the oxygen tension in rat muscle and tumor; 2) the developed pulse sequence can successfully monitor the rat thigh muscle oxygen dynamics; 3) HMDSO spin-lattice relaxation time (T1) in tumor responds to respiratory intervention (air-oxygen-air); 4) BOLD imaging signal intensity in tumor also responds to respiratory intervention (air-oxygen-air).
So, Hexamethyldisiloxane shows promise as a reporter molecule to measure tumor oxygenation by 1 H MRS and potentially by MRI. This opens new opportunities for MR tumor oximetry, particularly since HMDSO is used widely in biomedical materials and as an ingredient in consumer products; and HMDSO is reported to have minimal toxicity. PISTOL successfully monitored the modulation of tissue oxygenation in response to oxygen challenge. The short total acquisition time (3 min per pO 2 measurement) reveals dynamic response to oxygen intervention. This study further validates the use of HMDSO as a pO 2 reporter molecule. We believe that PISTOL has great potential for application in the clinic being a proton MRI approach using techniques, which can be implemented on clinical scanners. Lack of toxicity and commercial availability add to the promise of HMDSO as a pO 2 reporter molecule. F NMR resonances of fluorocarbons on pO 2 is well known and has been studied extensively. We recently presented hexamethyldisiloxane (HMDSO) as a potential analogous 1 H NMR pO 2 reporter molecule . HMDSO has a single proton NMR resonance, which is ideal for imaging. 1H MRI of reporter molecules is subject to potential interference from the large water and fat resonances, but the chemical shift of -5 ppm relative to water allows chemical shift selective imaging. We now demonstrate application with bulk pO 2 measurements and pO 2 maps obtained in vivo in rat thighs and tumors following a direct intra tissue injection of 100 μl HMDSO. Dynamic changes in pO 2 were assessed with respect to respiratory challenge. Given the minimal toxicity and ready availability of HMDSO, we believe it has great potential for ultimate application as a pO 2 Modulation of tissue oxygenation in response to oxygen challenge was successfully monitored by bulk spectroscopy and imaging. The short total acquisition time reveals dynamic response to therapeutic interventions. Minimal toxicity and wide availability add to the promise of HMDSO as a pO 2 reporter molecule. We believe it has great potential for application in the clinic especially as all the techniques used can be implemented on clinical scanners.
Proton Imaging of Silanes to map Tissue Oxygenation Levels (PISTOL): a new tool for quantitative tissue oximetry

